1. Home
  2. OLPX vs LQDA Comparison

OLPX vs LQDA Comparison

Compare OLPX & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLPX
  • LQDA
  • Stock Information
  • Founded
  • OLPX 2014
  • LQDA 2004
  • Country
  • OLPX United States
  • LQDA United States
  • Employees
  • OLPX N/A
  • LQDA N/A
  • Industry
  • OLPX Package Goods/Cosmetics
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OLPX Consumer Discretionary
  • LQDA Health Care
  • Exchange
  • OLPX Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • OLPX 1.1B
  • LQDA 957.2M
  • IPO Year
  • OLPX 2021
  • LQDA 2018
  • Fundamental
  • Price
  • OLPX $1.58
  • LQDA $12.89
  • Analyst Decision
  • OLPX Hold
  • LQDA Strong Buy
  • Analyst Count
  • OLPX 5
  • LQDA 7
  • Target Price
  • OLPX $2.30
  • LQDA $26.67
  • AVG Volume (30 Days)
  • OLPX 1.5M
  • LQDA 794.1K
  • Earning Date
  • OLPX 02-27-2025
  • LQDA 03-12-2025
  • Dividend Yield
  • OLPX N/A
  • LQDA N/A
  • EPS Growth
  • OLPX N/A
  • LQDA N/A
  • EPS
  • OLPX 0.06
  • LQDA N/A
  • Revenue
  • OLPX $433,646,000.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • OLPX N/A
  • LQDA N/A
  • Revenue Next Year
  • OLPX $0.17
  • LQDA $213.65
  • P/E Ratio
  • OLPX $26.35
  • LQDA N/A
  • Revenue Growth
  • OLPX N/A
  • LQDA N/A
  • 52 Week Low
  • OLPX $1.19
  • LQDA $8.26
  • 52 Week High
  • OLPX $2.77
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • OLPX 33.47
  • LQDA 64.85
  • Support Level
  • OLPX $1.47
  • LQDA $11.34
  • Resistance Level
  • OLPX $1.64
  • LQDA $12.58
  • Average True Range (ATR)
  • OLPX 0.09
  • LQDA 0.48
  • MACD
  • OLPX -0.00
  • LQDA 0.05
  • Stochastic Oscillator
  • OLPX 30.14
  • LQDA 97.48

About OLPX Olaplex Holdings Inc.

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies consumers' most relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through a global omnichannel platform serving the professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates major revenue from Professional sales channel followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from International market.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: